Q3 2025 Financial Performance - Net sales reached $178 million, reflecting 10% organic growth[18] - Adjusted EPS stood at $0.36[18] - Adjusted EBITDA amounted to $20 million with an 11% margin[18] Segment Performance - Specialty Nutrition Systems experienced 14.5% organic growth, with net sales of $114 million[20] - Specialty Nutrition Systems operating profit was $23 million, representing a 20% margin[21] - Pain Management & Recovery saw 2.4% organic growth, with net sales of $59 million[26] 2025 Outlook - Net sales are estimated to be between $690 million and $700 million[16, 33] - Adjusted EPS is projected to be between $0.85 and $0.95 per share[16, 33] Financial Position - Cash balance was $70 million as of September 30, 2025[31] - Net debt was $(33) million, with a net debt to EBITDA ratio of approximately 0.4x[31] Strategic Initiatives - Expanded transformation initiatives are expected to deliver $15 to $20 million of incremental annualized savings by the end of 2026[16]